| 000 | 01508 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513213155.0 | ||
| 264 | 0 | _c20000706 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diabetes.49.2.253 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRashid, S | |
| 245 | 0 | 0 |
_aBeta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. _h[electronic resource] |
| 260 |
_bDiabetes _cFeb 2000 |
||
| 300 |
_a253-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aCarbachol |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEpinephrine _xblood |
| 650 | 0 | 4 |
_aHyperglycemia _xetiology |
| 650 | 0 | 4 |
_aHyperinsulinism _xblood |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNorepinephrine _xblood |
| 650 | 0 | 4 |
_aPropranolol _xtherapeutic use |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aStress, Physiological _xblood |
| 700 | 1 | _aShi, Z Q | |
| 700 | 1 | _aNiwa, M | |
| 700 | 1 | _aMathoo, J M | |
| 700 | 1 | _aVandelangeryt, M L | |
| 700 | 1 | _aBilinski, D | |
| 700 | 1 | _aLewis, G F | |
| 700 | 1 | _aVranic, M | |
| 773 | 0 |
_tDiabetes _gvol. 49 _gno. 2 _gp. 253-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.49.2.253 _zAvailable from publisher's website |
| 999 |
_c10819739 _d10819739 |
||